Product references — Chromium
Anton, S., et al. 2008. Effects of chromium picolinate on food intake and satiety.
Diabetes. Technol. Ther., 10 (5), 405–412. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/18715218
(accessed 12.16.2008).
Abdourahman, A., & Edwards, J. 2008. Chromium supplementation improves glucose
tolerance in diabetic Goto–Kakizaki rats. IUBMB Life, 60 (8), 541–548.
URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/18629917 (accessed 12.16.2008).
Horvath, E., et al. 2008. Antidiabetogenic effects of chromium mitigate hyperinsulinemia-induced
cellular insulin resistance via correction of plasma membrane cholesterol imbalance.
Mol. Endocrinol, 22 (4), 937–950. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/18165437
(accessed 12.16.2008).
Preuss, H., et al. 2008. Comparing metabolic effects of six different commercial
trivalent chromium compounds. J. Inorg. Biochem., 102 (11), 1986–1990.
URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/18774175 (accessed 12.16.2008).
Geohas, J., et al. 2007. Chromium picolinate and biotin combination reduces atherogenic
index of plasma in patients with type 2 diabetes mellitus: A placebo-controlled,
double-blinded, randomized clinical trial. Am. J. Med. Sci., 333 (3), 145–153.
URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/17496732 (accessed 12.09.2008).
Broadhurst, C., & Domenico, P. 2006. Clinical studies on chromium picolinate
supplementation in diabetes mellitus — a review. Diabetes Technol. Ther.,
8 (6), 677–687. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/17109600
(accessed 12.16.2008).
Chen, G., et al. 2006. Chromium activates glucose transporter 4 trafficking and
enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent
mechanism. Mol. Endocrinol., 20 (4), 857–870. URL: http://mend.endojournals.org/cgi/content/full/20/4/857
(accessed 12.16.2008).
Pattar, G., et al. 2006. Chromium picolinate positively influences the glucose transporter
system via affecting cholesterol homeostasis in adipocytes cultured under hyperglycemic
diabetic conditions. Mutat. Res., 610 (1–2), 93–100. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=16870493
(accessed 12.16.2008).
Preuss, H., et al. 2001. Long-term effects of chromium, grape seed extract, and
zinc on various metabolic parameters of rats. Mol. Cell Biochem., 223 (1–2),
95–102. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/11681727 (accessed
12.16.2008).
Preuss, H., et al. 2000. Effects of niacin-bound chromium and grape seed proanthocyanidin
extract on the lipid profile of hypercholesterolemic subjects: A pilot study. J.
Med., 31 (5–6), 227–246. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/11508317
(accessed 12.09.2008).
Crawford, V., et al. 1999. Effects of niacin-bound chromium supplementation on body
composition in overweight African-American women. Diab. Obes. Metabol., 1
(6), 331–337. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/11225649
(accessed 12.09.2008).
McCarty, M. 1995. Anabolic effects of insulin on bone suggest a role for chromium
picolinate in preservation of bone density. Med. Hypotheses, 45 (3), 241–246.
URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/8569546 (accessed 12.09.2008).
Wilson, B., & Gondy, A. 1995. Effects of chromium supplementation on fasting
insulin levels and lipid parameters in healthy, non-obese young subjects. Diabet.
Res. Clin. Pract., 28 (3), 179–184. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/8529496
(accessed 12.09.2008).
Grant, K., et al. 1997. Chromium and exercise training: Effect on obese women. Med.
Sci. Sports Exerc., 29 (8), 992–998. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/9268955
(accessed 12.09.2008).